XIAO Zhi-jian, LU Ze-sheng. A Randomized Study of Clofarabine Versus Clofarabine Plus Low-Dose Cytarabine us Front-Line Therapy for Older Patients with Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome[J]. Journal of Evidence-Based Medicine, 2009, 9(5): 263-265. DOI: 10.3969/j.issn.1671-5144.2009.05.009
|
Citation:
|
XIAO Zhi-jian, LU Ze-sheng. A Randomized Study of Clofarabine Versus Clofarabine Plus Low-Dose Cytarabine us Front-Line Therapy for Older Patients with Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome[J]. Journal of Evidence-Based Medicine, 2009, 9(5): 263-265. DOI: 10.3969/j.issn.1671-5144.2009.05.009
|
XIAO Zhi-jian, LU Ze-sheng. A Randomized Study of Clofarabine Versus Clofarabine Plus Low-Dose Cytarabine us Front-Line Therapy for Older Patients with Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome[J]. Journal of Evidence-Based Medicine, 2009, 9(5): 263-265. DOI: 10.3969/j.issn.1671-5144.2009.05.009
|
Citation:
|
XIAO Zhi-jian, LU Ze-sheng. A Randomized Study of Clofarabine Versus Clofarabine Plus Low-Dose Cytarabine us Front-Line Therapy for Older Patients with Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome[J]. Journal of Evidence-Based Medicine, 2009, 9(5): 263-265. DOI: 10.3969/j.issn.1671-5144.2009.05.009
|
DownLoad: